NCT06170593View on ClinicalTrials.gov

Intralesional Injections of Triamcinolone for Acne Vulgaris

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

January 31, 2023

Study Completion Date

February 14, 2023

Conditions
Acne Vulgaris
Interventions
DRUG

Triamcinolone Injection

0.1mL of triamcinolone 1% solution per lesion

Trial Locations (1)

94538

Center For Dermatology Clinical Research, Inc, Fremont

Sponsors

Lead Sponsor

ACOM Labs
All Listed Sponsors
lead

ACOM Labs

INDUSTRY

NCT06170593 - Intralesional Injections of Triamcinolone for Acne Vulgaris | Biotech Hunter | Biotech Hunter